Python is a great language for automating everyday tasks, from managing files to interacting with websites. Libraries like ...

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them. This year, Visa Inc. (NYSE: V) has unveiled a scam ...

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them. Late last year, Lucid Group Inc. (NASDAQ: LCID) began ...

Joby is very close to being the first eVTOL company to get FAA-type certification. That first-mover advantage could set it up for a decade of growth. The company also has a powerful tech ally in ...

The company, established in the aftermath of 9/11, has skyrocketed since the launch of its Artificial Intelligence Platform (AIP) in 2023, which added an AI layer to its deep data analytics platform.

Netflix is putting a lot on the line to buy Warner Bros. Discovery. HBO’s content and pricing model complement Netflix well. Netflix is a high-margin cash cow that can grow steadily, regardless of the ...

SoundHound AI stock pulled back substantially in 2025, and more downside may be possible in 2026 due to its rich valuation. Another company capitalized on the growing demand for edge AI hardware, ...

GRAND JUNCTION, Colo. (KJCT) - Mesa County residents will pay more for water testing services starting January 1. The county’s regional testing lab is increasing fees for three different water tests.

The 2025 housing market is off to a hot start. Home prices are stabilizing nationally, and inventory is increasing. Active listings were up almost 15.3% year-over-year in January, marking 15 straight ...

Almost exactly one year ago, Janux Therapeutics unveiled early data for its investigational T-cell engager that wowed investors and analysts alike. But the biotech’s newest update has failed to garner ...

The Nasdaq composite fell Monday as Broadcom and other AI-related stocks continued to weigh on tech shares. Indexes have been volatile this month, as worries around the artificial-intelligence boom ...

Rezolute’s stock has plunged 87% after the company’s rare disease drug flunked the final clinical test ahead of a planned approval application. The company had been evaluating ersodetug as a treatment ...